Proteogenomic Characterization of Endometrial Carcinoma

Cited by (499)

Items 101–200 of 499

1. The metabolomic landscape of rice heterosis highlights pathway biomarkers for predicting complex phenotypes
   Zhiwu Dan, Yunping Chen, Hui Li, Yafei Zeng, Wuwu Xu, Weibo Zhao, Ruifeng He, Wenchao Huang · 2021 · PLANT PHYSIOLOGY
2. Enhanced Multiplexing Technology for Proteomics
   Bailey L. Bowser, Renã A. S. Robinson · 2023 · Annual Review of Analytical Chemistry
3. Functional Impact of Protein–RNA Variation in Clinical Cancer Analyses
   Gali Arad, Tamar Geiger · 2023 · Molecular & Cellular Proteomics
4. Comprehensive evaluation of phosphoproteomic-based kinase activity inference
   Sophia Müller‐Dott, Eric J. Jaehnig, Khoi Pham Munchic, Wen Jiang, Tomer M. Yaron, Sara R. Savage, Martín Garrido‐Rodríguez, Jared Lee Johnson, Alessandro Lussana, Evangelia Petsalaki et al. · 2025 · Nature Communications
5. Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells
   Alejandro La Greca, Nicolás Bellora, François Le Dily, Rodrigo Jara, Ana Silvina Nacht, Javier Quilez, José Luis Villanueva‐Cañas, Enrique Vidal, Gabriela Alejandra Merino, Cristóbal Fresno et al. · 2022 · eLife
6. MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer
   Xiaomei Sun, Lingtong Hou, Chunping Qiu, Beihua Kong · 2021 · Cellular & Molecular Biology Letters
7. Mass Spectrometry–Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine
   Sunil Kumar Joshi, Paul Piehowski, Tao Liu, Sara J.C. Gosline, Jason McDermott, Brian J. Druker, Elie A. Traer, Jeffrey W Tyner, Anupriya Agarwal, Cristina E. Tognon et al. · 2023 · The Annual Review of Pharmacology and Toxicology
8. Identification and validation of serum metabolite biomarkers for endometrial cancer diagnosis
   Wanshan Liu, Jinglan Ma, Juxiang Zhang, Jing Cao, Xiaoxiao Hu, Yida Huang, Ruimin Wang, Jiao Wu, Wen J. Di, Kun Qian et al. · 2024 · EMBO Molecular Medicine
9. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response
   Zhe Hu, Zimeng Wu, Wei Liu, Yan Ning, Jingbo Liu, Wencheng Ding, Junpeng Fan, Shuyan Cai, Qinlan Li, Wenting Li et al. · 2024 · Nature Genetics
10. UBE2C -mediated Autophagy Inhibition via Ubiquitination of SIRT1 Contributes to Endometrial Cancer Progression
    Rong Zhao, Yan Liu, Ziwei Wang, Jun Zhang, Wei Zhang, Xing Zhou, Sevjid Tsedendorj, Amarsanaa Enkhtur, Dilu Feng, Hongbo Wang · 2023 · Molecular Cancer Research
11. Patient-Specific Multi-Omics Models and the Application in Personalized Combination Therapy
    August J. John, Bo Qin, Krishna R. Kalari, Liewei Wang, Jia Yu · 2020 · Future Oncology
12. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target
    Alison Kurimchak, Vikas S. Kumar, Carlos Herrera-Montávez, Katherine J. Johnson, Nishi Srivastava, Karthik Davarajan, Suraj Peri, Kathy Qi Cai, Gina M. Mantia-Smaldone, James S. Duncan · 2020 · Molecular & Cellular Proteomics
13. A Simple Optimization Workflow to Enable Precise and Accurate Imputation of Missing Values in Proteomic Data Sets
    Kruttika Dabke, Simion D. Kreimer, Michelle R. Jones, Sarah J. Parker · 2021 · Journal of Proteome Research
14. Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer
    Leyi Ni, Chengyun Tang, Yuning Wang, Jiaming Wan, Morgan G. Charles, Zilong Zhang, Chen Li, Ruijie Zeng, Yiyao Jin, Penghao Song et al. · 2022 · Journal of Personalized Medicine
15. Integration of androgen hormones in endometrial cancer biology
    Marija Gjorgoska, Tea Lanišnik Rižner · 2022 · Trends in Endocrinology and Metabolism
16. Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML
    Sara J.C. Gosline, Cristina E. Tognon, Michael D. Nestor, Sunil Kumar Joshi, Rucha V. Modak, Alisa Damnernsawad, Camilo Posso, Jamie Moon, Joshua Hansen, Chelsea M. Hutchinson-Bunch et al. · 2022 · Clinical Proteomics
17. Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications
    Sander R. Piersma, Andrea Vallés‐Martí, Frank Rolfs, Thang V. Pham, Alex A. Henneman, Connie R. Jiménez · 2022 · Mass Spectrometry Reviews
18. Pan‐Cancer landscape of protein activities identifies drivers of signalling dysregulation and patient survival
    Abel Sousa, Aurélien J. F. Dugourd, Danish Memon, Borgþór Pétursson, Evangelia Petsalaki, Julio Sáez-Rodríguez, Pedro Beltrão · 2023 · Molecular Systems Biology
19. Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia
    James C. Pino, Camilo Posso, Sunil Kumar Joshi, Michael D. Nestor, Jamie Moon, Joshua Hansen, Chelsea M. Hutchinson-Bunch, Marina Gritsenko, Karl Weitz, Kevin Watanabe‐Smith et al. · 2024 · Cell Reports Medicine
20. Circular RNAs: A Promising Biomarker for Endometrial Cancer
    Jialu Guo, Jinyi Tong, Jianfeng Zheng · 2021 · Cancer Management and Research
21. Proteogenomic analysis of cancer aneuploidy and normal tissues reveals divergent modes of gene regulation across cellular pathways
    2022
22. Clinical proteomics towards multiomics in cancer
    Chad J. Creighton · 2022 · Mass Spectrometry Reviews
23. Tumors Widely Express Hundreds of Embryonic Germline Genes
    Jan Willem Bruggeman, Naoko Irie, Paul Lodder, Ans M. M. van Pelt, Jan Köster, Geert Hamer · 2020 · Cancers
24. Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
    Jeffrey R. Whiteaker, Rachel A. Lundeen, Lei Zhao, Regine M. Schoenherr, Aura Burian, Dongqing Huang, Uliana J. Voytovich, Tao Wang, Jacob J. Kennedy, Richard G. Ivey et al. · 2021 · Frontiers in Immunology
25. IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway
    Shi, Rui, Zhao, Rong, Shen, Yan, Wei, Sitian, Zhang, Tangansu, Zhang, Jun, Shu, Wan, Cheng, Shuangshuang, Teng, Hua, Wang, Hongbo · 2024 · Cancer Gene Therapy
26. Alternate RNA decoding results in stable and abundant proteins in mammals
    Shira Tsour, Rainer Machné, Andrew Leduc, Simon D. Widmer, Eunice Koo, Jérémy Guez, Konrad J. Karczewski, Nikolai Slavov · 2026 · Nature
27. The status of proteomics as we enter the 2020s: Towards personalised/precision medicine
    Edouard Collins Nice · 2020 · Analytical Biochemistry
28. DEAD-box RNA helicase protein DDX21 as a prognosis marker for early stage colorectal cancer with microsatellite instability
    Atsushi Tanaka, Julia Y. Wang, Jinru Shia, Yihua Zhou, Makiko Ogawa, Ronald C. Hendrickson, David S. Klimstra, Michael H. A. Roehrl · 2020 · Scientific Reports
29. Spatially interacting phosphorylation sites and mutations in cancer
    Kuan‐lin Huang, Adam David Scott, Daniel Cui Zhou, Liang-Bo Wang, Amila Weerasinghe, Abdülkadir Elmas, Ruiyang Liu, Yige Wu, Michael C. Wendl, Matthew A. Wyczalkowski et al. · 2021 · Nature Communications
30. Glycoproteogenomics: Setting the Course for Next-Generation Cancer Neoantigen Discovery for Cancer Vaccines
    José Alexandre Ferreira, Marta Relvas‐Santos, Andreia Peixoto, André M. N. Silva, Lúcio Lara Santos · 2021 · Genomics Proteomics & Bioinformatics
31. m6A mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer
    Peng Ruan, Shujun Wang, Chaoyi Yang, Xiaohui Huang, Pengxing Sun, Aili Tan · 2022 · Cell Biology and Toxicology
32. Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG
    Jingwen Deng, Shaoxia Liao, Chaoyi Chen, Fengyan Han, Siqin Lei, Xuan Lai, Kehong Ye, Qizheng Han, E Fang, Chao Tsang Lu et al. · 2023 · Cell Death and Disease
33. Magneto: Combining Small and Large Language Models for Schema Matching
    Yurong Liu, Eduardo H. M. Pena, Aécio S. R. Santos, Eden Wu, Juliana Freire · 2025 · Proceedings of the VLDB Endowment
34. Pan-cancer proteogenomic analysis reveals long and circular noncoding RNAs encoding peptides
    Ghofran Othoum, Emily M. Coonrod, Sidi Zhao, Ha X. Dang, Christopher A. Maher · 2020 · NAR Cancer
35. Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group
    Nadja Stiegeler, Dale W. Garsed, George Au‐Yeung, David D.L. Bowtell, Viola A Heinzelmann-Schwarz, Tibor Andrea Zwimpfer · 2024 · Frontiers in Oncology
36. Protein-based classification reveals an immune-hot subtype in IDH mutant astrocytoma with worse prognosis
    Jihong Tang, Wenhua Fan, Yuyan Ruan, Xing Liu, Fufang Qiu, Jie Feng, Guoshi Huang, Mengli Yan, Hui Wang, Quanhua Mu et al. · 2025 · Cancer Cell
37. OmicLoupe: facilitating biological discovery by interactive exploration of multiple omic datasets and statistical comparisons
    Jakob Willforss, Valentina Siino, Fredrik Levander · 2021 · BMC Bioinformatics
38. Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors
    Ivan Cohen, Fresia G. Pareja, Nicholas D. Socci, Ronglai Shen, Ashley S. Doane, Jazmin Schwartz, Raya Khanin, Elizabeth Ann Morris, Elizabeth Jane Sutton, Ronald G. Blasberg · 2022 · Frontiers in Immunology
39. In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression
    Ana Montero‐Calle, Álvaro López‐Janeiro, Marta L. Mendes, Daniel Pérez-Hernández, Irene Echevarría, Ignacio Ruz‐Caracuel, Victoria Heredia-Soto, Marta Mendiola, David Hardisson, Pablo Argüeso et al. · 2023 · Cellular Oncology
40. Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
    Huan Li, Chao Song, Yang Zhang, Guohao Liu, Hailong Mi, Yachao Li, Zhiye Chen, Xiaoyu Ma, Po Zhang, Lidong Cheng et al. · 2023 · Advanced Science
41. Construction and Validation of a Ferroptosis-Related Prognostic Model for Endometrial Cancer
    Hao Wang, Yingchen Wu, Shengfu Chen, Minzhi Hou, Yanning Yang, Meiqing Xie · 2021 · Frontiers in Genetics
42. CircESRP1 enhances metastasis and epithelial–mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis
    Rui Shi, Wei Zhang, Jun Zhang, Zhicheng Yu, Lanfen An, Rong Zhao, Xing Zhou, Ziwei Wang, Sitian Wei, Hongbo Wang · 2022 · Journal of Translational Medicine
43. The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep learning
    Sarah Volinsky-Fremond, Viktor Hendrik Koelzer, Nanda Horeweg, Tjalling Bosse · 2022 · Frontiers in Oncology
44. Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review
    Andrea Romano, Tea Lanišnik Rižner, Henrica M.J. Werner, Andrzej Semczuk, Camille Lowy, Christoph Schröder, Anne Griesbeck, Jerzy Adamski, Dmytro Fishman, Janina Tokarz · 2023 · Frontiers in Oncology
45. Proteomic analysis reveals microvesicles containing NAMPT as mediators of radioresistance in glioma
    Elena Panizza, Brandon D. Regalado, Fangyu Wang, Ichiro Nakano, Nathaniel M. Vacanti, Richard A. Cerione, Marc A. Antonyak · 2023 · Life Science Alliance
46. A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
    Jun Li, Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou, Zhenlin Ju, Shwetha V. Kumar, Patrick Kwok‐Shing Ng, Han Chen, Michael A. Davies et al. · 2024 · Nature Cancer
47. SWATH-MS Analysis of FFPE Tissues Identifies Stathmin as a Potential Marker of Endometrial Cancer in Patients Exposed to Tamoxifen
    Lucia Janáčová, Jakub Faktor, Lenka Čápková, Vendula Páralová, Anna Pospisilova, Ján Podhorec, Holger Alexander Ebhardt, Roman Hrstka, Rudolf Nenutil, Ruedi H. Aebersold et al. · 2020 · Journal of Proteome Research
48. Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers
    Guo-Sheng Hu, Zaozao Zheng, Yaohui He, Du-chuang Wang, Rui-chao Nie, Wen Liu · 2025 · Molecular & Cellular Proteomics
49. Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics
    Jixin Wang, Wen Yu, Rachel K. D’Anna, Anna Przybyła, Matt Wilson, Matthew S. Sung, John Bullen, Elaine M. Hurt, Gina D’Angelo, Ben S. Sidders et al. · 2023 · Molecular & Cellular Proteomics
50. MMP12 is a Potential Predictive and Prognostic Biomarker of Various Cancers Including Lung Adenocarcinoma
    Guosheng Li, Yu-Xing Tang, Wei Zhang, Jian‐Di Li, Heqing Huang, Jun Liu, Zong-Wang Fu, Rong‐Quan He, Jinliang Kong, Hua‐Fu Zhou et al. · 2024 · Cancer Control
51. Deciphering the dark cancer phosphoproteome using machine-learned co-regulation of phosphosites
    Wen Jiang, Eric J. Jaehnig, Yuxing Liao, Zhiao Shi, Tomer M. Yaron, Jared Lee Johnson, Lewis C. Cantley, Bing Zhang · 2025 · Nature Communications
52. Relevance of ARID1A Mutations in Endometrial Carcinomas
    Antonio De Leo, Gloria Ravegnini, Francesco Musiani, Thais Maloberti, Michela Visani, Viviana Sanza, Sabrina Angelini, Anna Myriam Perrone, Pierandrea De Iaco, Angelo Gianluca Corradini et al. · 2022 · Diagnostics
53. Exploring the pan-cancer landscape of posttranscriptional regulation
    Umesh Ghoshdastider, Ataman Sendoel · 2023 · Cell Reports
54. A Deep Learning‐Based Tumor Classifier Directly Using MS Raw Data
    Hao Dong, Yi Liu, Wenfeng Zeng, Kunxian Shu, Yunping Zhu, Cheng Chang · 2020 · PROTEOMICS
55. A highly multiplexed quantitative phosphosite assay for biology and preclinical studies
    Hasmik Keshishian, E. Robert McDonald, Filip Mundt, Randy Melanson, Karsten Krug, DALE A. PORTER, Luke Wallace, Dominique Forestier, Bokang Rabasha, Sara Marlow et al. · 2021 · Molecular Systems Biology
56. Comprehensive PTM profiling with SCASP-PTM uncovers mechanisms of p62 degradation and ALDOA-mediated tumor progression
    Zhan-Peng Lin, Guohong Gan, Xiao Xu, Chengwen Wen, Xin Ding, Xiangyu Chen, Kaijie Zhang, Wenyu Guo, Mingxin Lin, Yu-Yang Wang et al. · 2025 · Cell Reports
57. CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers
    Guosheng Li, Wei Zhang, Wanying Huang, Rong‐Quan He, Zhi‐Guang Huang, Xiang-Yu Gan, Zhen Yang, Yi‐Wu Dang, Jinliang Kong, Hua‐Fu Zhou et al. · 2023 · BMC Pulmonary Medicine
58. Pan-cancer proteogenomic investigations identify post-transcriptional kinase targets
    Abdülkadir Elmas, Serena Tharakan, Suraj K. Jaladanki, Matthew D. Galsky, Tao Liu, Kuan‐lin Huang · 2021 · Communications Biology
59. SIMSI-Transfer: Software-Assisted Reduction of Missing Values in Phosphoproteomic and Proteomic Isobaric Labeling Data Using Tandem Mass Spectrum Clustering
    Firas Hamood, Florian P Bayer, Mathias Wilhelm, Bernhard Küster, Matthew The · 2022 · Molecular & Cellular Proteomics
60. Research progress of neoantigens in gynecologic cancers
    Yu‐Li Song, Yi Zhang · 2022 · International Immunopharmacology
61. Inflammation and tumor microenvironment.
    Tao Niu, Fenghai Zhou · 2023 · PubMed Central
62. A community effort to identify and correct mislabeled samples in proteogenomic studies
    Seungyeul Yoo, Zhiao Shi, Bo Wen, Soon Jye Kho, Renke Pan, Hanying Feng, Hong Chen, Anders Carlsson, Patrik Edén, Weiping Ma et al. · 2021 · Patterns
63. OmicsEV: a tool for comprehensive quality evaluation of omics data tables
    Bo Wen, Eric J. Jaehnig, Bing Zhang · 2022 · Bioinformatics
64. Multi-omics profiling reveal cells with novel oncogenic cluster, TRAP1low/CAMSAP3low, emerge more aggressive behavior and poor-prognosis in early-stage endometrial cancer
    Xiaodan Mao, Xiaoyue Tang, Jingxuan Ye, Xu Shuxia, Yue Wang, Xianhua Liu, Qibin Wu, Xite Lin, Maotong Zhang, Jiang‐Feng Liu et al. · 2024 · Molecular Cancer
65. Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing
    Wenkang Fu, Yanyan Lin, Mingzhen Bai, Jia Yao, Chongfei Huang, Long Gao, Ningning Mi, Haidong Ma, Liang Tian, Ping Yue et al. · 2024 · Acta Pharmaceutica Sinica B
66. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
    Yuqing Ren, Yi Yue, Xinyang Li, Siyuan Weng, Hui Xu, Long Liu, Quan Cheng, Peng Luo, Tengfei Zhang, Zaoqu Liu et al. · 2024 · International Immunopharmacology
67. Transcriptome features of striated muscle aging and predictability of protein level changes
    Han Yu, Lauren Z. Li, Nikhitha Kastury, Cody T. Thomas, Maggie P. Y. Lam, Edward Lau · 2021 · Molecular Omics
68. Proteogenomic landscape of uterine leiomyomas from hereditary leiomyomatosis and renal cell cancer patients
    Nicholas W. Bateman, Christopher M. Tarney, Tamara S. Abulez, Anthony R. Soltis, Ming Zhou, Kelly A. Conrads, Tracy A. Litzi, Julie Oliver, Brian L. Hood, Paul H. Driggers et al. · 2021 · Scientific Reports
69. BlackSheep: A Bioconductor and Bioconda Package for Differential Extreme Value Analysis
    Lili M. Blumenberg, Emily A. Kawaler, MacIntosh Cornwell, Shaleigh A. Smith, Kelly V. Ruggles, David Fenyö · 2021 · Journal of Proteome Research
70. Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
    Hongmei Gu, Jiahang Song, Yizhang Chen, Yichun Wang, Xiaofang Tan, Hongyu Zhao · 2022 · Frontiers in Oncology
71. MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection
    Yang Cao, Dan Wang, Jin Wu, Zhanxin Yao, Si Shen, Chao Niu, Ying Liu, Pengcheng Zhang, Quannian Wang, Jinhao Wang et al. · 2023 · Briefings in Bioinformatics
72. Deep Learning Prediction Boosts Phosphoproteomics-Based Discoveries Through Improved Phosphopeptide Identification
    Xinpei Yi, Bo Wen, Shuyi Ji, Alexander B. Saltzman, Eric J. Jaehnig, Jonathan Thomas Lei, Qiang Gao, Bing Zhang · 2023 · Molecular & Cellular Proteomics
73. Integrating Multi-Omics in Endometrial Cancer: From Molecular Insights to Clinical Applications
    Hye Kyeong Kim, Tae Jin Kim · 2025 · Cells
74. The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma
    Xiaojuan Liu, Hui Ma, Lisha Ma, Kun Li, Yanhua Kang · 2022 · Bioengineered
75. A new strategy in molecular typing: the accuracy of an NGS panel for the molecular classification of endometrial cancers
    Yang Li, Junnan Feng, Chengzhi Zhao, Meng Lin, Shanshan Shi, Kangdong Liu, Jie Ma · 2022 · Annals of Translational Medicine
76. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling
    Dong Zhang, Rui Sun, C. Di, Lin Li, Faming Zhao, Yu Han, Wenjie Zhang · 2023 · Computers in Biology and Medicine
77. The evolving role of immune checkpoint inhibitors in cervical and endometrial cancer
    Bertha Alejandra Martínez-Cannon, Ilaria Colombo · 2024 · Cancer Drug Resistance
78. Inflammation-related citrullination of matrisome proteins in human cancer
    Pekka Rappu, Ujjwal Suwal, Elina Siljamäki, Jyrki Heino · 2022 · Frontiers in Oncology
79. Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival
    Katherine C. Kurnit, Bryan M. Fellman, Gordon Brent Mills, Jessica L. Bowser, Su-Su Xie, Russell R. Broaddus · 2022 · International Journal of Gynecological Cancer
80. Proteomics appending a complementary dimension to precision oncotherapy
    Zhaokai Zhou, Ruiqi Zhang, Aoyang Zhou, Jinxiang Lv, Shuang Chen, Haijiao Zou, Ge Zhang, Ting Lin, Zhan Wang, Yuyuan Zhang et al. · 2024 · Computational and Structural Biotechnology Journal
81. Robust collection and processing for label-free single voxel proteomics
    Reta Birhanu Kitata, Marija Veličković, Zhangyang Xu, Rui Zhao, David Scholten, Rosalie Chu, Danny Orton, William Chrisler, Tong Zhang, Jeremy Abraham Mathews et al. · 2025 · Nature Communications
82. SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner
    Zhiyi Hu, Ming Tang, Yujia Huang, Bailian Cai, Xiaoxiang Sun, Guofang Chen, Ao Huang, Xiaoqi Li, Ab Rauf Shah, Lijun Jiang et al. · 2025 · Nature Communications
83. Precision Proteogenomics Reveals Pan-Cancer Impact of Germline Variants
    Fernanda Martins Rodrigues, Nadezhda V. Terekhanova, K. Imbach, Karl R. Clauser, Myvizhi Esai Selvan, I. Mendizabal, Yifat Geffen, Y. Akiyama, Myranda Maynard, T. Yaron et al. · 2025 · Cell
84. Variant biomarker discovery using mass spectrometry-based proteogenomics
    Luke Reilly, Sahba Seddighi, Andrew Singleton, Mark Cookson, Michael Emmerson Ward, Yue Andy Qi · 2023 · Frontiers in Aging
85. Comparison of clinical characteristics and prognosis between type I and type II endometrial cancer: a single-center retrospective study
    Yuanpei Wang, Yi Sun, Fangfang Sun, Han Pin, Rujia Fan, Fang Ren · 2023 · Discover Oncology
86. Development and validation of m6A regulators’ prognostic significance for endometrial cancer
    Xuecheng Pang, Xiang Zhang, Yue Huang, Sumin Qian · 2021 · Medicine
87. CRABP2 – A novel biomarker for high-risk endometrial cancer
    Donagh Egan, Bruce Moran, Michael Wilkinson, Miquel Pinyol, Esther Guerra, Sónia Gatius, Xavier Matías‐Guiu, Walter Kölch, Carel Wynand le Roux, Donal J. Brennan · 2022 · Gynecologic Oncology
88. Explore the alterations of downstream molecular pathways caused by ARID1A mutation/knockout in human endometrial cancer cells
    Baoling Xing, Xiaoying Zhang, Xia Gu, Lintao Xiang, Cuiping Wang, Yueling Jin · 2023 · Journal of Cancer Research and Clinical Oncology
89. The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities
    Xingyuan Zhang, Sayali Joseph, Di Wu, Jessica L. Bowser, Cyrus Vaziri · 2024 · NAR Cancer
90. SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer
    Seema Prashanth, Radhika Radha Maniswami, Gurukumari Rajajeyabalachandran, Sooriya Kumar Jegatheesan · 2024 · Drug Discovery Today
91. Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape
    Silvia González-Martínez, Belén Perez‐Mies, Javier Cortés, José Palacios · 2024 · Frontiers in Immunology
92. Global research trends and focus on immunotherapy for endometrial cancer: a comprehensive bibliometric insight and visualization analysis (2012-2024)
    Yachen Xu, Tao Wang, Xiaojing Liang, Jie Yang, Yuxiang Zhang, Shan Bao · 2025 · Frontiers in Immunology
93. Interpretable Machine Learning for Proteomics‐Based Subtyping and Tumor Mutational Burden Prediction in Endometrial Cancer
    Thi‐My‐Trang Luong, Xuan‐Thanh Bui, Chii‐Ruey Tzeng, Nguyen Quoc Khanh Le · 2025 · PROTEOMICS - CLINICAL APPLICATIONS
94. Hsa_circ_0075960 Serves as a Sponge for miR-361-3p/SH2B1 in Endometrial Carcinoma
    Bo Wu, Ailing Ren, Ying Tian, Ruizhen Huang · 2020 · Technology in Cancer Research & Treatment
95. In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer
    Eva Coll-de la Rubia, Elena Martínez-García, Gunnar A. G. Dittmar, Petr V. Nazarov, Vicente Bebia, Sílvia Cabrera, Antonio Gil‐Moreno, Eva Colás · 2021 · Cancers
96. CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma
    Yanli Liu, Wanmei Liang, Yabin Chang, Zehui He, Meijian Wu, Haozhi Zheng, Xinrong Ke, Minjia Lv, Qingqian Liu, Qinyu Liu et al. · 2022 · Frontiers in Immunology
97. Cancer Serum Atlas-Supported Precise Pan-Targeted Proteomics Enable Multicancer Detection
    Anqi Hu, Lei Zhang, Zhenxin Wang, Chunyan Yuan, Ling Lin, Jiayi Zhang, Xia Gao, Xuguang Chen, Wei Guo, Pengyuan Yang et al. · 2022 · Analytical Chemistry
98. Rational Construction of a Novel Bioluminescent Substrate for Sensing the Tumor-Associated Hydrolase Notum
    Li-Lin Song, Mengru Sun, Jinhui Shi, Zhenhao Tian, Yuqing Song, Huixin Liu, Shanshan Zhao, Heng Yin, Guang‐Bo Ge · 2023 · Analytical Chemistry
99. Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms
    Seiichi Mori, Osamu Gotoh, Kazuma Kiyotani, Siew‐Kee Low · 2021 · Journal of Human Genetics
100. MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues
     Jennifer G. Abelin, Erik J. Bergstrom, Hannah B. Taylor, Keith D. Rivera, Susan Klaeger, Charles Xu, C. Jackson White, Meagan E. Olive, Myranda Maynard, M. Harry Kane et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)